Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Hoffman, S. Rosengren, D. Boyle, J. Cho, J. Nayar, James Mueller, Justin Anderson, A. Wanderer, G. Firestein (2004)
Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonistThe Lancet, 364
J. Leake, G. Billman, M. Nespeca, S. Duthie, C. Dory, H. Meltzer, J. Bradley (2002)
Pediatric acute hemorrhagic leukoencephalitis: report of a surviving patient and review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 34 5
F. Bienaimé, M. Dragon-Durey, C. Regnier, Sara Nilsson, Wing-hong Kwan, J. Blouin, M. Jablonski, N. Renault, M. Rameix-Welti, C. Loirat, C. Sautès-Fridman, B. Villoutreix, A. Blom, V. Frémeaux-Bacchi (2010)
Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome.Kidney international, 77 4
Isabel Ponce-Castro, C. González-Rubio, E. Delgado-Cerviño, C. Abarrategui-Garrido, G. Fontán, P. Sánchez-Corral, M. López-Trascasa (2008)
Molecular characterization of Complement Factor I deficiency in two Spanish families.Molecular immunology, 45 10
J. Beek, Kristina Elward, P. Gasque (2003)
Activation of Complement in the Central Nervous SystemAnnals of the New York Academy of Sciences, 992
T. Vyse, P. Späth, K. Davies, B. Morley, P. Philippe, P. Athanassiou, C. Giles, M. Walport (1994)
Hereditary complement factor I deficiency.QJM : monthly journal of the Association of Physicians, 87 7
B. Silverman, D. Carney, C. Johnston, P. Vanguri, M. Shin (1984)
Isolation of Membrane Attack Complex of Complement from Myelin Membranes Treated with Serum ComplementJournal of Neurochemistry, 42
C. Dinarello (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.Blood, 117 14
D. Kavanagh, A. Richards, M. Noris, R. Hauhart, M. Liszewski, D. Karpman, J. Goodship, V. Frémeaux-Bacchi, G. Remuzzi, T. Goodship, J. Atkinson (2007)
Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.Molecular immunology, 45 1
AKM Chowdhury, T. Ehara, M. Higuchi, K. Hora, H. Shigematsu (2005)
Immunohistochemical detection of immunoglobulins and complements in formaldehyde‐fixed and paraffin‐embedded renal biopsy tissues; an adjunct for diagnosis of glomerulonephritisNephrology, 10
M. Holland, D. Morikis, John Lambris (2004)
Synthetic small-molecule complement inhibitors.Current opinion in investigational drugs, 5 11
K. Palin, D. Verrier, V. Tridon, Jane Hurst, V. Perry, R. Dantzer, J. Lestage (2004)
Influence of the course of brain inflammation on the endogenous IL-1β/IL-1Ra balance in the model of brain delayed-type hypersensitivity response to bacillus Calmette–Guérin in Lewis ratsJournal of Neuroimmunology, 149
G. Kovacs, P. Gasque, T. Ströbel, E. Lindeck-Pozza, Michaela Strohschneider, J. Ironside, H. Budka, M. Guentchev (2004)
Complement activation in human prion diseaseNeurobiology of Disease, 15
P. Vanguri, C. Koski, B. Silverman, M. Shin (1982)
Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.Proceedings of the National Academy of Sciences of the United States of America, 79 10
S. Barnum, Jennifer Jones (1995)
Differential regulation of C3 gene expression in human astroglioma cells by interferon-γ and interleukin-1βNeuroscience Letters, 197
M. Griffiths, J. Neal, M. Fontaine, T. Das, P. Gasque (2009)
Complement Factor H, a Marker of Self Protects against Experimental Autoimmune Encephalomyelitis
K. Francis, J. Beek, Cecile Canova, J. Neal, P. Gasque (2003)
Innate immunity and brain inflammation: the key role of complementExpert Reviews in Molecular Medicine, 5
J. Rasmussen, B. Teisner, H. Jepsen, S. Svehag, F. Knudsen, H. Kirstein, M. Buhl (1988)
Three cases of factor I deficiency: the effect of treatment with plasma.Clinical and experimental immunology, 74 1
G. Hänsch, M. Seitz, M. Betz (1987)
Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation.International archives of allergy and applied immunology, 82 3-4
E. Payne, J. Rutka, T. Ho, W. Halliday, B. Banwell (2007)
Treatment Leading to Dramatic Recovery in Acute Hemorrhagic LeukoencephalitisJournal of Child Neurology, 22
Declaration of Funding NIH Training Grant T32 AI007469 (CG, LB) Conflict of Interest Dr. Hoffman is a consultant for Sobi Biovitrum
A. Basu, J. Krady, S. Levison (2004)
Interleukin‐1: A master regulator of neuroinflammationJournal of Neuroscience Research, 78
GS Hageman, DH Anderson, LV Johnson, LS Hancox, AJ Taiber, LI Hardisty (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degenerationProc Natl Acad Sci U S A, 102
Sara Nilsson, Robert Sim, S. Lea, V. Frémeaux-Bacchi, A. Blom (2011)
Complement factor I in health and disease.Molecular immunology, 48 14
C. González-Rubio, Antonio Ferreira-Cerdán, Isabel Ponce, J. Arpa, G. Fontán, M. López-Trascasa (2001)
Complement factor I deficiency associated with recurrent meningitis coinciding with menstruation.Archives of neurology, 58 11
A. Jauneau, A. Ischenko, P. Chan, M. Fontaine (2003)
Complement component anaphylatoxins upregulate chemokine expression by human astrocytesFEBS Letters, 537
Sara Nilsson, Nikolina Kalchishkova, L. Trouw, V. Frémeaux-Bacchi, B. Villoutreix, A. Blom (2009)
Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor IEuropean Journal of Immunology, 40
W. Delano (2002)
The PyMOL Molecular Graphics System
J. Atkinson, M. Liszewski, A. Richards, D. Kavanagh, E. Moulton (2005)
Hemolytic Uremic Syndrome: An Example of Insufficient Complement Regulation on Self‐TissueAnnals of the New York Academy of Sciences, 1056
P. Roversi, Steven Johnson, Joseph Caesar, F. McLean, K. Leath, S. Tsiftsoglou, B. Morgan, C. Harris, Robert Sim, S. Lea (2011)
Structural basis for complement factor I control and its disease-associated sequence polymorphismsProceedings of the National Academy of Sciences, 108
R. Goldbach-Mansky, Natalie Dailey, S. Canna, A. Gelabert, Janet Jones, B. Rubin, H. Kim, C. Brewer, C. Zalewski, E. Wiggs, S. Hill, M. Turner, B. Karp, I. Aksentijevich, F. Pucino, S. Penzak, M. Haverkamp, L. Stein, B. Adams, T. Moore, R. Fuhlbrigge, B. Shaham, J. Jarvis, K. O’neil, R. Vehe, L. Beitz, G. Gardner, W. Hannan, R. Warren, W. Horn, J. Cole, S. Paul, P. Hawkins, Tuyet-Hang Pham, Christopher Snyder, R. Wesley, S. Hoffmann, S. Holland, J. Butman, D. Kastner (2006)
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.The New England journal of medicine, 355 6
T. Maga, C. Nishimura, Amy Weaver, K. Frees, Richard Smith (2010)
Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndromeHuman Mutation, 31
Barry Peterson, S. Khanna, B. Fisher, L. Marshall (2000)
Prolonged hypernatremia controls elevated intracranial pressure in head‐injured pediatric patientsCritical Care Medicine, 28
P. Gasque, Yann Dean, E. McGreal, J. VanBeek, B. Morgan (2000)
Complement components of the innate immune system in health and disease in the CNS.Immunopharmacology, 49 1-2
S. Barnum, J. Jones (1995)
Differential regulation of C3 gene expression in human astroglioma cells by interferon-gamma and interleukin-1 beta.Neuroscience letters, 197 2
Sara Nilsson, D. Karpman, F. Vaziri-Sani, A. Kristoffersson, R. Salomon, F. Provôt, V. Frémeaux-Bacchi, L. Trouw, A. Blom (2007)
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.Molecular immunology, 44 8
Rae Baxter, K. Alt (1982)
Acknowledgments.-The authors would like to
J Beek, K Elward, P Gasque (2003)
Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotectionAnn N Y Acad Sci, 992
Daniel Ricklin, G. Hajishengallis, Kun Yang, John Lambris (2010)
Complement: a key system for immune surveillance and homeostasisNature Immunology, 11
V. Badovinac, M. Mostarica‐Stojković, C. Dinarello, S. Stošić-Grujičić (1998)
Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cellsJournal of Neuroimmunology, 85
Sara Nilsson, L. Trouw, N. Renault, M. Miteva, F. Genel, M. Zelazko, H. Marquart, K. Muller, A. Sjöholm, L. Truedsson, B. Villoutreix, A. Blom (2009)
Genetic, molecular and functional analyses of complement factor I deficiencyEuropean Journal of Immunology, 39
G. Rambach, H. Maier, G. Vago, I. Mohsenipour, C. Lass‐Flörl, Alexandra Defant, R. Würzner, M. Dierich, C. Speth (2008)
Complement induction and complement evasion in patients with cerebral aspergillosis.Microbes and infection, 10 14-15
S. Allan, P. Tyrrell, N. Rothwell (2005)
Interleukin-1 and neuronal injuryNature Reviews Immunology, 5
G. Naked, M. Florido, P. Paula, A. Vinet, J. Inostroza, Lourdes Isaac (2000)
Deficiency of human complement factor I associated with lowered factor H.Clinical immunology, 96 2
Anne Thomas, P. Gasque, D. Vaudry, B. Gonzalez, M. Fontaine (2000)
Expression of a complete and functional complement system by human neuronal cells in vitro.International immunology, 12 7
J Clin Immunol (2013) 33:162–171 DOI 10.1007/s10875-012-9767-z ORIGINAL RESEARCH Mutations of Complement Factor I and Potential Mechanisms of Neuroinflammation in Acute Hemorrhagic Leukoencephalitis Lori Broderick & Chhavi Gandhi & James L. Mueller & Christopher D. Putnam & Katayoon Shayan & Patricia C. Giclas & Karin S. Peterson & Seema S. Aceves & Robert M. Sheets & Bradley M. Peterson & Robert O. Newbury & Hal M. Hoffman & John F. Bastian Received: 3 July 2012 /Accepted: 9 August 2012 /Published online: 29 August 2012 Springer Science+Business Media, LLC 2012 Abstract Methods Extensive clinical workup of two patients pre- Purpose Acute Hemorrhagic Leukoencephalitis (AHLE) is senting with AHLE revealed complement abnormalities, a rare demyelinating disorder of acute onset, rapid deterio- specifically related to the alternative pathway and its ration and significant morbidity and mortality. Most often regulator, FI. Aggressive management with steroids, im- described as a post-infectious complication of an upper munoglobulin, and anakinra ultimately led to improve- respiratory illness, its precise pathophysiology remains un- ment of clinical status and near return to neurologic clear. We describe two pediatric patients with AHLE with baseline in both patients. Genetic sequencing of the FI partial complement factor I (FI) deficiency whose successful
Journal of Clinical Immunology – Springer Journals
Published: Aug 29, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.